After nearly two decades developing excimer lasers to treat both dermatological conditions and peripheral artery disease, Ra Medical is now pursuing a “divide and conquer” strategy with the sale of ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological ...
HORSHAM, Pa., Feb. 17, 2026 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative dermatologic ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED), today announced study results from Athar Ansari, MD, Director of the California Heart & Vascular Clinic, who stated, “DABRA is ...
STRATA Skin Sciences announces a study validating its Excimer Laser technology's superiority in treating dermatological conditions compared to traditional UVB sources. STRATA Skin Sciences, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results